1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with niacinamide in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (niacinamide) | Trials (niacinamide) | Recent Studies (post-2010) (niacinamide) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 13,381 | 1,097 | 5,797 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | niacinamide (IC50) |
---|---|---|---|
Chain A, NAD-dependent deacetylase | Thermotoga maritima | 1000 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 3.3 | |
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 2.9 | |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | 8.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imura, Y; Maezaki, N; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and niacinamide
Article | Year |
---|---|
Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
Topics: Animals; Azepines; Humans; Isoquinolines; Molecular Structure; Niacinamide; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines; Triazoles | 1991 |